
ESOPMay 19, 2026, 04:28 PM
AtriCure Stockholders Approve 2.25M Share Increase for Stock Plans
AI Summary
AtriCure, Inc. stockholders approved amendments to both the 2023 Stock Incentive Plan and the 2018 Employee Stock Purchase Plan at the Annual Meeting. The 2023 Stock Incentive Plan will now have 6,000,000 shares available, an increase of 1,500,000, while the 2018 Employee Stock Purchase Plan increased by 750,000 shares. Additionally, nine directors were elected, Deloitte & Touche LLP was ratified as the auditor, and executive compensation received advisory approval.
Key Highlights
- Stockholders approved increasing shares for the 2023 Stock Incentive Plan by 1,500,000 to 6,000,000.
- Stockholders approved increasing shares for the 2018 Employee Stock Purchase Plan by 750,000.
- Nine directors were elected to serve one-year terms expiring at the 2027 Annual Meeting.
- Deloitte & Touche LLP was ratified as the independent registered public accounting firm for 2026.
- Stockholders provided advisory approval for the compensation of named executive officers.
Price Impact
More from ATRC